Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1245 publications
Beyond CFTR: Ivacaftor's role in restoring cellular redox balance and preventing ferroptosis.
Journal: Redox biology
Published: November 14, 2025
Phenotypic and functional characterisation of liver-infiltrating T-cells in a case of CFTR modulator induced drug-induced liver injury.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 27, 2025
Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study.
Journal: International journal of molecular sciences
Published: October 10, 2025
Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: October 09, 2025
Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR.
Journal: Science progress
Published: October 07, 2025
CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis.
Journal: Cells
Published: October 02, 2025
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy.
Journal: Journal of health psychology
Published: October 02, 2025
New Role of Protein Misfolding Corrector in the ER Stress-Inflammation Axis: Possible Therapeutic Indication in Neuronal and Epithelial Tumor Cells.
Journal: International journal of molecular sciences
Published: September 22, 2025
CFTR during pregnancy and adverse drug reactions: A pharmacovigilance disproportionality analysis in VigiBase.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 19, 2025
Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 09, 2025
(R)-vanzacaftor potentiates BKCa channels in the absence of CFTR correction or potentiation.
Journal: American journal of physiology. Cell physiology
Published: September 08, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study.
Journal: Annals of the American Thoracic Society
Published: September 08, 2025
Last Updated: 01/07/2026